Kymera Therapeutics (KYMR) Earnings Date & Reports

A.I. Advisor

published Earnings

KYMR is expected to report earnings to rise 44.21% to -83 cents per share on November 07

Kymera Therapeutics KYMR Stock Earnings Reports

Q3'24

Est.

$-0.84

Q2'24

Beat

by $0.10

Q1'24

Beat

by $0.02

Q4'23

Beat

by $0.15

Q3'23

Missed

by $0.26

The last earnings report on August 07 showed earnings per share of -57 cents, beating the estimate of -68 cents. With 243.19K shares outstanding, the current market capitalization sits at 3.14B.

View a ticker or compare two or three

Compare

KYMR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For KYMR
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for KYMR (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a biotechnology company, which engages in curing untreatable diseases and focuses on discovering and developing novel small molecule therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

200 Arsenal Yards Boulevard

Phone

+1 857 285-5300

Employees

187

Web

https://www.kymeratx.com